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background:  About half of ACS present without ST-segment elevation. Current ESC guidelines for the management of NSTE-ACS 
recommend risk stratification to decide about the appropriateness of invasive treatment, including troponins which define the diagnosis 
of NSTEMI. Little is known about treatment and outcome differences between NSTEMI and unstable angina pectoris (UAP) in clinical 
practice.
methods:  Between Oct 2006 and Oct 2008, 21,872 consecutive patients with ACS were enrolled into the Euro-Heart-Survey ACS-Registry 
to document treatment and hospital outcome. We examined the differences between patients with NSTEMI and UAP.
Results:  A total of 13,018 patients (59.5%) presented with NSTE-ACS, 7,688 (59.1%) had NSTEMI, 5,330 (40.9%) had UAP. NSTEMI 
patients were older and more often suffered from diabetes, peripheral artery disease and renal failure. They were more likely to undergo 
an invasive strategy with early PCI as compared to patients with UAP. Despite the more aggressive treatment, NSTEM had a significantly 
higher in-hospital mortality and MI-rate. After correction for differences in baseline characteristics as well as in treatment strategy NSTEMI 
had a more than 4-fold increased risk of death (HR 4.19, p<0.001).
conclusion:  Patients presenting with NSTEMI more often were treated by coronary intervention as compared to UAP. However, NSTEMI 
was an independent predictor of hospital mortality in the patient population with NSTE-ACS with a more than 4-fold increased rate of death.
 
